Add Company
Join Now

Axovia Therapeutics Revenue and Competitors

License our Company Data API

London, UK

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Axovia Therapeutics's estimated annual revenue is currently $1.6M per year.(i)
  • Axovia Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Axovia Therapeutics has 10 Employees.(i)
  • Axovia Therapeutics grew their employee count by 67% last year.

Axovia Therapeutics's People

NameTitleEmail/Phone
1
Co-founder and Chief Scientific OfficerReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M35-12%N/AN/A
#2
$16.3M1054%N/AN/A
#3
$107.2M49425%$292MN/A
#4
$2.6M83030%$631.7MN/A
#5
$18.1M117-8%$81MN/A
#6
$1.2M27112%$440MN/A
#7
$54.6M2820%$132.9MN/A
#8
$9.3M60-37%N/AN/A
#9
$21.2M13712%N/AN/A
#10
$408.2M164611%£994.6MN/A
Add Company

What Is Axovia Therapeutics?

Axovia Therapeutics is dedicated to the research and development of novel AAV gene therapies that target key aspects of ciliopathies, addressing the devastating impact of the disease head-on for patients, their families and caregivers.\n\nAxovia is currently developing therapies for patients with mutations in the BBS1 gene which manifests as Bardet Biedl Syndrome. Our initial goal is to halt the progression of BBS by targeting the most debilitating aspects of the neurological, metabolic and retinal dysfunctions.

keywords:N/A

N/A

Total Funding

10

Number of Employees

$1.6M

Revenue (est)

67%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.5M10-9%N/A
#2
$0.9M100%$8M
#3
$1.3M10-17%N/A
#4
$0.9M10N/AN/A
#5
$0.9M10N/AN/A